DBI-001
Sponsors
DermBiont, Inc.
Conditions
Atopic DermatitisOnychomycosis
Phase 2
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
TerminatedNCT05253755
Start: 2021-10-06End: 2022-09-09Updated: 2023-11-08
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis
SuspendedNCT05491603
Start: 2023-11-30End: 2023-11-30Target: 60Updated: 2023-09-07